[Evolution of the regulatory framework in clinical research].

Bull Cancer

Centre Oscar-Lambret, direction de la recherche clinique et de l'innovation, 3, rue Combemale, 59020 Lille, France; Université Lille-Nord de France, faculté de médecine, place de Verdun, 59000 Lille, France. Electronic address:

Published: April 2019

The regulatory framework of clinical research is necessary to ensure the protection of participants and to define the actors and their responsibilities. Although main principles have been set up in 1947 with the Nuremberg Code, this regulatory framework is relatively recent in Europe: development of national regulations in the years 1980-1990, first European Directive regarding clinical trials in 2001. In France, as 2006 was marked by the implementation of this first "Clinical trials Directive", the end of the year 2016 and the following months were marked by the enforcement of the Jardé law (previously modified in order to reinforce the regulatory requirements following the death of an healthy volunteer in a clinical trial). As clinical researches involve processing of personal data, the entry into force, on 25 May 2018, of the General Data Protection Regulation (GDPR) had also consequences on their implementation. Finally, regarding clinical trials on drugs, the "Clinical trials Regulation" repealing the Directive, voted in 2014, should come into force in the coming months.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2019.01.016DOI Listing

Publication Analysis

Top Keywords

regulatory framework
12
framework clinical
8
clinical trials
8
"clinical trials
8
clinical
6
[evolution regulatory
4
clinical research]
4
research] regulatory
4
clinical ensure
4
ensure protection
4

Similar Publications

This scoping review aims to understand the cell-based meat production process, including the regulations, potential hazards, and critical points of this production. This review includes studies on cultured meat production processes, health hazards, and regulatory guidelines, excluding those without hazard analysis, incomplete texts, or studies published before 2013. The search was performed in eight electronic databases (MEDLINE, Web of Science, Embase, Cochrane Library, Scopus, LILACS, and Google Scholar) using MeSH terms and adaptations for each database.

View Article and Find Full Text PDF

Effect of SNORD113-3/ADAR2 on glycolipid metabolism in glioblastoma via A-to-I editing of PHKA2.

Cell Mol Biol Lett

January 2025

Key Laboratory of Neuro-Oncology in Liaoning Province, Shenyang, 110004, China.

Background: Glioblastoma multiforme (GBM) is a highly aggressive brain tumor, characterized by its poor prognosis. Glycolipid metabolism is strongly associated with GBM development and malignant behavior. However, the precise functions of snoRNAs and ADARs in glycolipid metabolism within GBM cells remain elusive.

View Article and Find Full Text PDF

Comprehensive discovery and functional characterization of the noncanonical proteome.

Cell Res

January 2025

The Center for RNA Medicine, International Institutes of Medicine, International School of Medicine, The 4th Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, China.

The systematic identification and functional characterization of noncanonical translation products, such as novel peptides, will facilitate the understanding of the human genome and provide new insights into cell biology. Here, we constructed a high-coverage peptide sequencing reference library with 11,668,944 open reading frames and employed an ultrafiltration tandem mass spectrometry assay to identify novel peptides. Through these methods, we discovered 8945 previously unannotated peptides from normal gastric tissues, gastric cancer tissues and cell lines, nearly half of which were derived from noncoding RNAs.

View Article and Find Full Text PDF

Recent advances in synthetic biology toolkits and metabolic engineering of Ralstonia eutropha H16 for production of value-added chemicals.

Biotechnol Adv

January 2025

Frontier Science Center for Synthetic Biology (Ministry of Education), Key Laboratory of Systems Bioengineering, and School of Chemical Engineering and Technology, Tianjin University, Tianjin 300350, China; College of Life and Health Sciences, Northeastern University, Shenyang 110169, China. Electronic address:

Ralstonia eutropha H16, a facultative chemolithoautotrophic Gram-negative bacterium, demonstrates remarkable metabolic flexibility by utilizing either diverse organic substrates or CO as the sole carbon source, with H serving as the electron donor under aerobic conditions. The capacity of carbon and energy metabolism of R. eutropha H16 enabled development of synthetic biology technologies and strategies to engineer its metabolism for biosynthesis of value-added chemicals.

View Article and Find Full Text PDF

Co-occurrence of microplastics, PFASs, antibiotics, and antibiotic resistance genes in groundwater and their composite impacts on indigenous microbial communities: A field study.

Sci Total Environ

January 2025

State Key Laboratory of Soil and Sustainable Agriculture, Institute of Soil Science, Chinese Academy of Sciences, Nanjing 211135, China; University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address:

There is a major gap in the occurrence of mixed emerging contaminants, which hinders our efforts in exploring their behaviors and transport in environmental media, as well as their toxicity to human and ecosystem. This study assessed the occurrence and their correlations of mixed contamination by microplastics (MPs), per- and polyfluoroalkyl substances (PFASs), antibiotics, and antibiotic resistance genes (ARGs) in groundwater collected from a pharmaceutical and chemical industrial park. MPs, PFASs, antibiotics and ARGs were detected at all monitoring wells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!